CTChanana Dorcas Tsayang

Chanana Dorcas Tsayang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chanana Dorcas Tsayang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surveillance of Pathogenic Bacteria and Antimicrobial Resistance Determinants in Surface Water and Human Plasma Using Metagenomic Sequencing in the Ngamiland and Okavango Delta Regions

    by Patience Motshosi, Kabo Baruti, Lindiwe Ndlangamandla, Phenyo Sabone, Wonderful Tatenda Choga, Tsholofelo Sethibe, Gorata G. A. Mpebe, Chanana Dorcas Tsayang, Florence G. Gaongalelwe, Simani Gaseitsiwe, et al.

    (1) Background: Antimicrobial resistance poses a critical global public health threat, with surface water acting as a potential reservoir for pathogenic, zoonotic, and AMR determinants and transmission pathways between humans and animals. We aimed to detect bacterial DNA of clinically relevant taxa and putative AMR determinants in surface water and human beings to support the expansion of One Health environmental surveillance in the Ngamiland and Okavango Delta regions. (2) Methods: We performed a cross-sectional environmental surveillance study using metagenomic sequencing. We collected 28 surface-water samples from Thamalakane River and Moremi Game Reserve sampling sites: 12 samples from Mall of Maun, Island Safari Lodge, and Police Bridge sites along the Thamalakane River, and 16 samples from Xakanaxa, Maxwexwana, Paradise, and Jessie’s Pools sites in Moremi Game Reserve. Additionally, 72 human plasma samples from Letsholathebe II Memorial District Hospital in Maun were also sequenced. Taxonomic classification was performed using Kraken2, and predictive AMR gene identification was performed using the CZ ID AMR module. Beta-diversity was assessed using Principal Coordinates Analysis and PERMANOVA for significant differences in bacterial and AMR gene composition. A p-value of less than 0.05 was considered to be statistically significant. (3) Results: Thamalakane River was dominated by Acinetobacter schindleri (~27%), Acinetobacter lwoffii (~67%), and the toxic cyanobacterium Microcystis aeruginosa (~99%). Moremi Game Reserve sites showed more varied dominant bacterial species, including Stenotrophomonas maltophilia at two sites (~26% and ~29%), Microcystis aeruginosa (~60%), P. aeruginosa (~20%), P. putida (~13%), and A. baumannii (~10%). Beta diversity analysis suggested differences in bacterial community composition between locations (PERMANOVA: R2 = 0.261, p = 0.001). Only 5 out of 28 bacterial species identified were shared between surface water and human plasma samples. No putative AMR genes were detected in human samples. However, only intrinsic efflux pump genes (mex-, sme-, ade-families, etc.) dominated surface water. Beta diversity analysis suggested differences in bacterial community composition between locations. (4) Conclusions: Detection of bacterial DNA of clinically relevant bacterial taxa in both surface water and human samples and putative AMR determinants in surface water samples only highlights the need for expanded One Health environmental surveillance. Even though no putative AMR genes were detected in human plasma, monitoring the emergence and transmission of pathogens and resistance-associated genes between One Health interfaces remains a significant research area that requires further investigation.

  • Open Access

    Deep Sequencing of Hepatitis B Virus Reveals Clinically Relevant Low-Frequency Variants Among People Living with HIV in Botswana

    by Tsholofelo Sethibe, Wonderful Tatenda Choga, Florence G. Gaongalelwe, Bonolo B. Phinius, Gorata G. A. Mpebe, Kabo Baruti, Chanana Dorcus Tsayang, Goabaone Mbae, Basetsana Katlo S. Phakedi, Patience Motshosi, et al.

    (1) Background: The Hepatitis B virus (HBV) is characterized by extensive genetic diversity, including low-frequency variants that contribute to disease progression. We aimed to characterize low-frequency variants and evaluate their potential clinical impact. (2) Methods: We utilized 104 HBV near-full-length sequences generated using next-generation sequencing (NGS) from people living with HIV (PLHIV). We used an in-house bioinformatics suite (HBVgenomeR v5.9.7) to filter for low-frequency variants (5–50%), which were compared to escape and drug resistance mutations (DRMs) and hepatocellular carcinoma (HCC)-associated mutations reported at the consensus level. Unclassified variants were characterized by HBV open reading frames (ORFs) to determine mutation frequency per genomic region. (3) Results: A total of six escape mutations were detected in 8/104 (7.7%) sequences, with surfaceN131T being the most prevalent (5/8). We also observed six DRMs in 30/104 (28.8%), with rtV173L being the most prevalent (21/30). Truncation mutations were also observed with rtA181T/sW172* and rtM204I/sW196L being the most prevalent. A total of 8/104 (7.7%) sequences had four variants associated with HCC. The xP46S was the highest observed HCC-associated mutation at 5/8. We report 1152 unique uncharacterized variants across all ORFs, and these were found in 94/104 (90.4%) sequences. The RNaseH domain had the highest burden (330/1152, 28.6%). (4) Conclusions: Deep sequencing results identified clinically significant mutations, including those below the 20% detection limit of traditional sequencing, that would go unreported. This highlights the possible underreporting of mutational burden in people living with HBV/HIV, indicating the importance of deep sequencing to aid in HBV/HIV understanding and management.

  • Open Access

    High Prevalence of Hepatitis B Virus Infection Among People Living with Advanced HIV Disease in Botswana

    by Chanana D. Tsayang, Emily Schanzer, Bonolo B. Phinius, Graceful Mulenga, Kesaobaka Molebatsi, Kwana Lechiile, Lynnette Bhebhe, Tsholofelo Ratsoma, Gorata G. A. Mpebe, Fredah Mulenga, et al.

    Background: Concomitant HIV/HBV infection results in worse health outcomes, with HBV reactivations being observed in immunocompromised individuals. However, data on HBV infection in people with advanced HIV disease (AHD) remains sparse in Botswana. We aimed to determine the prevalence and molecular characteristics of HBV in people living with HIV (PLHIV) with CD4+ T-cell counts ≤100 cells/µL in Botswana. Methods: Plasma samples (n = 1097) of PLHIV with CD4+ T-cell count ≤100 cells/uL collected between 2014 and 2016 were screened for hepatitis B surface antigen (HBsAg) and HBV core antibodies (anti-HBc). A 415bp region of the HBV surface gene was amplified and sequenced using Sanger sequencing. Genotypic and mutational analysis was performed using Geno2pheno. Adjusted prevalence ratios (aPRs) were estimated from a modified Poisson regression model to explore factors associated with HBV infection. p-values < 0.05 indicated statistical significance. Results: The median age was 37 years (IQR: 32–43), and 565/1097 (51.5%) were male. HBsAg prevalence was 10.6% (95%CI: 8.8–12.5%) and anti-HBc prevalence was 50.0% (95%CI:46.9–52.9%). Factors associated with HBV infection were male sex [aPR: 1.6 (p < 0.01)] and those that were ART-experienced [aPR: 1.43 (p = 0.04). Eighteen samples were successfully genotyped. The prevalence of genotype A was (12/18, 66.7%) and D (6/18, 33.3%). Sixty-three mutations were identified as associated with drug resistance and immune and diagnostic escape. Highly prevalent immune escape mutations in the surface region were S207N (12/63, 19%) and A194V (9/63, 14.3%). V163I (12/63, 19%) and M129L (12/63, 19%) were highly prevalent in the reverse transcriptase region. Two classical lamivudine-associated drug resistance mutations were observed, each occurring in one participant (L180M and V173L). Conclusions: The prevalence of HBV in people with AHD is high, highlighting the importance of HBV screening and HIV/HBV co-management in this population.

  • Open Access

    Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV

    by Kabo Baruti, Wonderful T. Choga, Patience C. Motshosi, Bonolo B. Phinius, Basetsana Phakedi, Lynnette N. Bhebhe, Gorata G. A. Mpebe, Chanana D. Tsayang, Tsholofelo Ratsoma, Tendani Gaolathe, et al.

    Hepatitis delta virus (HDV) co-infections more often result in severe hepatitis compared to hepatitis B virus (HBV) infections alone. Despite a high HDV prevalence (7.1%), information regarding circulating HDV clades is very limited in Botswana. We extracted total nucleic acid from confirmed HDV-positive samples and quantified their viral load. We then sequenced the large hepatitis delta antigen (L-HDAg) using Oxford Nanopore Technology (ONT). Genotyping was performed using the HDV Database, and HDV mutation profiling was performed on AliView. All participants with HBV genotypic information belonged to sub-genotype A1, and 80% (4/5) of them had a higher HDV viral load and a lower HBV viral load. We sequenced 75% (9/12) of the HDV-positive samples, which belonged to HDV clade 8. A total of 54 mutations were discovered, with the most prevalent being Q148R (16%), D149P (16%) and G151D (16%). Known mutations such as S117A, K131R, R139K and G151D were detected, while the other mutations were novel. Our results reveal that HDV clade 8 is the predominant clade in Botswana. The significance of all mutations remains unclear. Future studies with a larger sample size to detect other HDV clades that might be circulating in Botswana and functionally characterize the detected mutations are warranted.